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Introduction
There were 28 patients with psoriatic arthritis observed
amongst the children at the Hospital of the I.M. Sechenov
First Moscow State Medical University over the last
10 years.
Objectives
There were immediate tasks needing to be addressed to
reveal the specific clinical processes by which the children
with psoriatic arthritis were affected by the disease, by its
formation, its skin and joint syndromes, and the variations
in the initiation and peaking of the disease.
Methods
All the children were given general, biochemical, and
immunological blood tests. In addition to these, they
also received magneto-acoustic tomography (MAET)
and X-raying of the affected joints.
Results
The majority of the children (53%) were found to have
acquired the disease at about the age of 6-1/2 years.
The median age for the start of the disease was 6.2 +/-
0.5 years, with the youngest being at 4 months and the
oldest at 15 years. The mean duration of the disease was
6.7 +/- 0.3 years. In 29% of the cases, the disease began
from a skin infection. The effect on the joints began
after 2.4 +/- 0.3 years. The joint syndrome was observed
in 70.6% of the children with related skin indications
showing up on average after 4.5 +/- 0.8 years. Notably,
one female patient afflicted with arthritis for 8 years had
no signs of skin overpatching.
Our research showed that for 17.6% of the patients
the allergoseptic debut of the disease was accompanied
by fever, typical rash, and lymphadenopathy. According
to published scientific data, the hepatolienal syndrome,
or any involvement of the disease with the inner organs,
is not typical of psoriatic arthritis. In 11.8% of the
patients there was a general deterioration of the joints
including the cervical parts of the vertebral column as
shown in Still’s syndrome type. In 70.6% of the cases,
oligoarticular asymmetrical joint syndrome was found to
have spread from an initial affection of the ankle joints,
to the knee joints, and the proximal interphalangeal
joints and hip joints.
Our findings indicate that psoriatic arthritis varies its
course in different patients. In 47% of the children, the
disease was characterized by high laboratorial and clinical
activity with the exacerbation of joint and skin alteration
increasing up to 5 to 6 times per year. In 53%, the pro-
cess was much less pronounced with a positive effect
from standard antirheumatic therapy being observed.
At the height of the disease at 3 to 4 years from
beginning the observations, 41.2% of the patients were
diagnosed with a symmetrical oligoarthritis, spondyloar-
thritis was reported in 23.5% with affection occurring in
the peripheral joints, the ankle joints, knee joints, and
the interphalangeal joints, and in 11.8% there was arthritis
mutilans.
Our research showed that in 47% of the patients, the
disease symptoms corresponded to the 1st stage of the
Stein-Broker rentological scale, and in the other 53% to
the 3rd and 4th stages. It should be noted in passing, that
periarticular osteoporosis is effectively indistinguishable
in patients from psoriastic arthritis.
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Conclusion
The course of psoriatic arthritis in children is unpredict-
able and different from the same disease in adults.
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